Beroni Group Ltd logo

Beroni Group Ltd

0001851651

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the U.S.A. Its core businesses include cell therapies, developing new anti-cancer drugs, an e-commerce platform, and infectious disease detection. The group aims to become a world leader in the biotechnology, life sciences, and environmental science industries. Noted for its focus on cancer treatments and international collaborations.

80
Meget Pålitelig
Tillitsscore

Offisielt Register

MVA Nummer
000000000
Adresse
SUITE 401, 447 KENT STREET, SYDNEY, C3 NSW 2000
Bransjekoder
Pharmaceutical Preparations, 2834

AI Kvalitetsanalyse

Bransje
Biotechnology
SSL/HTTPS
Sikker
Profesjonell E-post
Ja
Kontakt E-post
enquiry@beronigroup.com

Tillitsscore Detaljer

Register Verifisert35/35
Kvalitetsscore45/60
Nyhetsanalyse0/5
Sist oppdatert: 1/2/2026

🌟 Lignende Pålitelige Bedrifter

SANGAMO THERAPEUTICS, INC

SANGAMO THERAPEUTICS, INC logo
86/100 · Meget Pålitelig

Sangamo Therapeutics is pioneering the future of genomic medicine, translating groundbreaking science into tomorrow’s cures. They leverage their deep scientific expertise and proprietary zinc finger platform to develop innovative therapies. The company is focused on developing treatments for genetic diseases.

501 CANAL BLVD., USA
Se profil

Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc. logo
89/100 · Meget Pålitelig

Allogene Therapeutics is a clinical-stage biotechnology company focused on developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. They have a fully integrated team dedicated to research, development, and cell manufacturing. Their goal is to deliver "off-the-shelf" CAR T cell candidates faster and more reliably.

210 EAST GRAND AVENUE, USA
Se profil

Neumora Therapeutics, Inc.

Neumora Therapeutics, Inc. logo
86/100 · Meget Pålitelig

Neumora was founded to improve the lives of patients with brain diseases. They develop precision medicines for brain diseases, focusing on novel mechanisms of action and therapeutically relevant targets. The company leverages a precision medicine approach to identify targeted patient populations.

260 ARSENAL PLACE, USA
Se profil